Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Prevalence of Presbyopia (Near Vision Fatigue) and Related Factors Among Working Adults Aged 30 to 55 Years in Shanghai (FOCUS)

perjantai 6. marraskuuta 2026 päivittänyt: Shanghai Eye Disease Prevention and Treatment Center

Prevalence and Associated Factors of Presbyopia Among Working Adults Aged 30-55 Years in Shanghai, China: A Cross-Sectional Study

This observational study aims to determine how common presbyopia is among working adults aged 30-55 years in Shanghai, China, and identify factors associated with it. Presbyopia is an age-related loss of the eye's ability to focus on nearby objects, which can make reading and other close-up activities difficult.

Participants will undergo eye examinations and complete questionnaires about their vision, work activities, use of digital screens, lifestyle, and need for vision correction. The study aims to obtain valid primary outcome data from at least 1,366 participants. It will also assess how closely the results of the NVC mini-program agree with a professional eye examination. No treatment will be assigned as part of the study.

Tutkimuksen yleiskatsaus

Tila

Ei vielä rekrytointia

Ehdot

Yksityiskohtainen kuvaus

This cross-sectional observational study will investigate the prevalence of presbyopia (near fatigue) and associated factors among working adults aged 30-55 years in Shanghai, China. Eligible participants must have worked in their current position for at least one year and provide written informed consent.

Industry-stratified two-stage sampling will be used, with the ISIC Rev.5 classification as the industry stratification framework. At the first stage, workplaces are randomly selected from candidate workplace rosters within each industry stratum; the study plans to include at least 15 independent workplaces covering at least 5 ISIC Rev.5 sections. At the second stage, eligible employees are randomly sampled from complete, de-duplicated employee rosters of the selected workplaces; if the number of eligible employees in a workplace does not exceed the planned invitation quota, all eligible employees are invited. The target is at least 1,366 participants with valid primary outcome data. Allowing for an estimated combined nonresponse and unusable primary outcome data rate of 20%, at least 1,708 individuals will need to be invited.

Data collection will include questionnaires and standardized ophthalmic examinations. Questionnaires will assess demographic and occupational characteristics, near-work demands, screen exposure, sleep, outdoor activities, lifestyle, ocular symptoms, awareness of presbyopia, previous correction, and correction needs and preferences. The NAVQ-P and OSDI questionnaires will assess near-vision difficulties and ocular surface symptoms. Examinations will assess distance, intermediate, and near visual acuity, refraction, near addition power (ADD), accommodative function, and ocular health. NVC mini-program outputs, including presbyopia severity categories and recommended ADD ranges, will also be recorded.

The primary outcome is the prevalence of presbyopia. Presbyopia is defined as binocular near visual acuity worse than N8 at 40 cm under best distance correction, improving by at least one line to N8 or better with additional positive spherical lenses, after excluding other ocular diseases sufficient to explain the reduction in near vision.

Secondary assessments will describe visual function, the relationship between accommodative amplitude and age, awareness of presbyopia, and correction needs. Associations with demographic, occupational, refractive, behavioral, and dry-eye-related factors will be examined. Analyses will account for industry stratification, workplace clustering, and unequal sampling probabilities as appropriate.

Agreement between NVC outputs and subjective refraction ADD will be assessed using overall percent agreement, the proportions of classifications differing by one grade and by two or more grades, and Kendall's tau-b correlation between NVC grades and clinical grades. The proportion of reference ADD values falling within the NVC-recommended ranges will also be calculated. No treatment will be assigned as part of this observational study.

Opintotyyppi

Havainnollistava

Ilmoittautuminen (Arvioitu)

1366

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskeluyhteys

  • Nimi: Xiangui He MD, PhD
  • Puhelinnumero: 021-53555032
  • Sähköposti: xianhezi@163.com

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

30 vuotta - 55 vuotta (Aikuinen)

Hyväksyy terveitä vapaaehtoisia

Joo

Sukupuolet, jotka voivat opiskella

Kaikki

Näytteenottomenetelmä

Todennäköisyysnäyte

Tutkimusväestö

Working adults aged 30-55 years employed in their current position for at least one year, recruited from at least 15 independent workplaces in Shanghai covering at least 5 ISIC Rev.5 industry sectors (education; manufacturing; construction; human health and social work activities; financial and insurance activities; public administration; professional, scientific and technical activities; administrative and support service activities). Within each workplace, eligible employees are randomly sampled from complete, de-duplicated rosters; if eligible employees do not exceed the planned invitation quota, all are invited. Participants are examined regardless of presbyopia status; the target population includes people with and without presbyopia.

Kuvaus

Inclusion Criteria:

  • Aged 30 to 55 years inclusive, based on date of birth on the national identification card
  • Either sex
  • Employed in the current position for at least one year
  • Willing to participate and able to provide written informed consent
  • Able to complete the questionnaire and the ophthalmic examinations

Exclusion Criteria:

  • Active ocular inflammation, significant ocular trauma, or other acute ocular condition within the past 3 months that precludes visual function testing
  • Previous intraocular surgery that substantially affects refractive status or visual function assessment, such as cataract surgery or refractive lens surgery
  • Obvious cognitive impairment, severe psychiatric disease, or other condition preventing cooperation with the survey and examinations
  • Markedly reduced best-corrected distance visual acuity with ocular disease sufficient to explain the near vision abnormality, including but not limited to adult amblyopia, significant corneal scarring, keratoconus, severe corneal dystrophy, significant lens opacity, and severe macular or optic nerve disease
  • Severe fundus or optic nerve disease, including macular degeneration, significant maculopathy, retinal detachment, optic atrophy or advanced glaucoma
  • Any other condition judged by the investigators to make participation unsuitable

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Havaintomallit: COHORT
  • Aikanäkymät: CROSS_SECTIONAL

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Prevalence of presbyopia among working adults aged 30 to 55 years in Shanghai
Aikaikkuna: Day 1 (At the single study visit (cross-sectional assessment))

Proportion of participants meeting the study definition of presbyopia: binocular near visual acuity worse than N8 (equivalent to 20/50) at 40 cm under standard illumination with full distance refractive correction, improving by at least one line to N8 or better after binocular addition of plus lenses, after exclusion of organic ocular disease that could independently explain reduced near vision. Reported as a percentage with 95 percent confidence interval, overall and stratified by 5-year age group, sex, occupation, education level, refractive status and screen exposure level.

Day 1 (At the single study visit (cross-sectional assessment))

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Amplitude of accommodation by age group
Aikaikkuna: Day 1 (At the single study visit (cross-sectional assessment))

Amplitude of accommodation in diopters, measured by the push-up method under full distance correction, repeated three times per eye and averaged. Reported as mean and standard deviation or median and interquartile range by 5-year age group, and used to fit the accommodation-age curve.

Day 1 (At the single study visit (cross-sectional assessment))
Adjusted odds ratios for factors associated with presbyopia
Aikaikkuna: Day 1 (At the single study visit (cross-sectional assessment))

Association of presbyopia with age, sex, education level, occupation and job type, refractive status, near-work duration, screen exposure, sleep duration and quality, outdoor activity and dry eye measures, estimated by generalized estimating equations or mixed-effects logistic regression with workplace as a clustering variable or random effect. Reported as adjusted odds ratios with 95 percent confidence intervals.

Day 1 (At the single study visit (cross-sectional assessment))
Awareness of presbyopia and need for near vision correction
Aikaikkuna: Day 1 (At the single study visit (cross-sectional assessment))

Description: Questionnaire-based assessment of awareness and understanding of presbyopia, previous care-seeking, current correction methods and wearing time, acceptance of correction options, acceptable price range, and future intention to use correction. Near vision-related quality of life assessed with the Chinese version of the Near Activity Visual Questionnaire for Presbyopia (NAVQ-P). Reported as frequencies and percentages.

Day 1 (At the single study visit (cross-sectional assessment))
Correlation between presbyopia severity grade and dry eye severity grade
Aikaikkuna: Day 1 (At the single study visit (cross-sectional assessment))

Dry eye graded as mild, moderate or severe based on the Ocular Surface Disease Index (OSDI), non-invasive tear break-up time, tear meniscus height and slit-lamp findings. Correlation with presbyopia severity grade assessed by Spearman rank correlation and, where appropriate, ordinal logistic regression adjusted for age, sex, refractive status, screen exposure and near-work load.

Day 1 (At the single study visit (cross-sectional assessment))
Agreement between NVC mini-program outputs and subjective refraction
Aikaikkuna: Day 1 (At the single study visit (cross-sectional assessment))

The near-fatigue severity grade and recommended ADD range output by the NVC mini-program will be compared with the reference ADD obtained by subjective refraction. Agreement measures include overall percent agreement, the proportion of classifications differing by one grade, the proportion differing by two or more grades, and Kendall's tau-b correlation between NVC grades and clinical grades. The proportion of reference ADD values falling within the NVC-recommended ranges will also be calculated.

Day 1 (At the single study visit (cross-sectional assessment))

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Arvioitu)

Sunnuntai 1. marraskuuta 2026

Ensisijainen valmistuminen (Arvioitu)

Perjantai 1. tammikuuta 2027

Opintojen valmistuminen (Arvioitu)

Perjantai 1. tammikuuta 2027

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Tiistai 3. marraskuuta 2026

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Perjantai 6. marraskuuta 2026

Ensimmäinen Lähetetty (Todellinen)

Maanantai 9. marraskuuta 2026

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Maanantai 9. marraskuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Perjantai 6. marraskuuta 2026

Viimeksi vahvistettu

Sunnuntai 1. marraskuuta 2026

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Muita asiaankuuluvia MeSH-ehtoja

Muut tutkimustunnusnumerot

  • IIT2026-015

Yksittäisten osallistujien tietojen suunnitelma (IPD)

Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?

EI

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa